| Employment |
| No Relationships to Disclose |
|
|
| Leadership |
| No Relationships to Disclose |
|
|
| Stock and Other Ownership Interests |
| No Relationships to Disclose |
|
|
| Honoraria |
| No Relationships to Disclose |
|
|
| Consulting or Advisory Role |
| Company: Karyopharm Therapeutics |
| Recipient: You |
| Company: Daiichi Sankyo/Lilly |
| Recipient: You |
| Company: Deciphera |
| Recipient: You |
| Company: Epizyme |
| Recipient: You |
|
| Speakers' Bureau |
| No Relationships to Disclose |
|
|
| Research Funding |
| Company: Medpacto, Inc. |
| Recipient: Your Institution |
| Company: Plexxikon |
| Recipient: Your Institution |
| Company: Daiichi Sankyo |
| Recipient: Your Institution |
| Company: Lilly |
| Recipient: Your Institution |
| Company: Immune Design |
| Recipient: Your Institution |
| Company: GlaxoSmithKline |
| Recipient: Your Institution |
| Company: TRACON Pharma |
| Recipient: Your Institution |
| Company: Advenchen Laboratories |
| Recipient: Your Institution |
| Company: Adaptimmune |
| Recipient: Your Institution |
| Company: Deciphera |
| Recipient: Your Institution |
| Company: springworks |
| Recipient: Your Institution |
|
| Patents, Royalties, Other Intellectual Property |
| No Relationships to Disclose |
|
|
| Expert Testimony |
| No Relationships to Disclose |
|
|
| Travel, Accommodations, Expenses |
| No Relationships to Disclose |
|
|
| Other Relationship |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Uncompensated Relationships |
| No Relationships to Disclose |
|
|
| (OPTIONAL) Open Payments Link |
| not answered |
|
|